Gammagard liquid 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DX25F6XTF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $106,861
Award facts
- Contract value 100% obligated
- $106,861.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $106,861.20 on September 15, 2025, for the supply of Gammagard Liquid 10% in 200 mL vials. The contract, which carries no set-aside designation, is expected to be completed by October 6, 2025, and will be performed at the contractor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that authorizes the issuance of firm fixed-price orders for pharmaceutical products supporting Department of Defense medical supply requirements.
The Defense Logistics Agency, through its Medical Supply Chain function, is funding this acquisition as part of its ongoing efforts to maintain pharmaceutical inventory for military health facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical distribution network, leveraging its status as a woman-owned small business to compete effectively in government procurement while maintaining a robust portfolio of branded and generic medications, biologics, and medical consumables. The Gammagard Liquid product being procured is an immunoglobulin therapy commonly used in Department of Defense healthcare settings for various immunodeficiency and immune-mediated conditions.
Quick answers
Who was awarded contract SPE2DX25F6XTF?
SPE2DX25F6XTF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 15, 2025.
How much is contract SPE2DX25F6XTF worth?
The government has obligated $106,861 on SPE2DX25F6XTF.
Is contract SPE2DX25F6XTF an order under another contract?
Yes. SPE2DX25F6XTF is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTF competed?
The extent of competition for SPE2DX25F6XTF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award